Nyxoah SA Long Term Debt 2021-2024 | NYXH
Nyxoah SA long term debt from 2021 to 2024. Long term debt can be defined as the sum of all long term debt fields.
| Nyxoah SA Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2023 | $12 |
| 2022 | $11 |
| 2021 | $12 |
| 2020 | $12 |
| Nyxoah SA Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2024-03-31 | $13 |
| 2023-12-31 | $12 |
| 2023-09-30 | $12 |
| 2023-06-30 | $12 |
| 2023-03-31 | $12 |
| 2022-12-31 | $11 |
| 2022-09-30 | $11 |
| 2022-06-30 | $12 |
| 2022-03-31 | $12 |
| 2021-12-31 | |
| 2021-03-31 | $13 |
| 2020-12-31 | $12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.449B | 20.01 |
| Inspire Medical Systems (INSP) | United States | $4.716B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.626B | 0.00 |
| Axonics (AXNX) | United States | $3.429B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.981B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.766B | 0.00 |
| Enovis (ENOV) | United States | $2.756B | 20.42 |
| Azenta (AZTA) | United States | $2.746B | 154.36 |
| 10x Genomics (TXG) | United States | $2.692B | 0.00 |
| Privia Health (PRVA) | United States | $2.065B | 115.40 |
| Schrodinger (SDGR) | United States | $1.597B | 0.00 |
| Omnicell (OMCL) | United States | $1.498B | 51.79 |
| Phreesia (PHR) | United States | $1.297B | 0.00 |
| Standard BioTools (LAB) | United States | $0.940B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.663B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.640B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.496B | 0.00 |
| Talkspace (TALK) | United States | $0.485B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.397B | 0.00 |
| Pulmonx (LUNG) | United States | $0.313B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.309B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.213B | 0.00 |
| Outset Medical (OM) | United States | $0.200B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.187B | 0.00 |
| TruBridge (TBRG) | United States | $0.151B | 8.10 |
| American Well (AMWL) | United States | $0.128B | 0.00 |
| 111 (YI) | China | $0.103B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.098B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.081B | 0.00 |
| HeartBeam (BEAT) | United States | $0.072B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.058B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.057B | 0.00 |
| Augmedix (AUGX) | United States | $0.056B | 0.00 |
| Zepp Health (ZEPP) | China | $0.046B | 0.00 |
| Movano (MOVE) | United States | $0.044B | 0.00 |
| CareCloud (CCLD) | United States | $0.041B | 0.00 |
| Akili (AKLI) | United States | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.029B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |